Immunocine Dendritic Cell Therapy for Colorectal Cancers

Colorectal cancers have been on the rise and now afflict more than 2 million humans per year, more than 150,000 Americans per year¹, and is simultaneously becoming one of the deadliest cancer categories across genders^{2, 3}.